Prostate cancer detection and treatment advancements

Medical experts emphasize the critical importance of early detection in prostate cancer, noting that the disease often progresses without obvious symptoms in its initial stages. Dr. Felipe Balbontín Fox of the Corporación Chilena Contra el Cáncer de Próstata warns that by the time symptoms like urinary discomfort or pain appear, the disease may already be advanced.

Early warning signs can include blood in the urine or semen, increased urinary frequency, and difficulty urinating. As the condition progresses, patients may experience back pain, bone pain, erectile dysfunction, or significant weight loss. Specialists recommend that men begin preventive screenings between ages 45 and 50, though those with family history or risk factors like obesity should start between 40 and 45. The Prostate-Specific Antigen (PSA) blood test remains a primary tool for detection.

Recent medical advancements are focused on improving tumor identification and personalizing treatments to avoid unnecessary procedures. Innovations in diagnostic tools and specialized analysis are helping clinicians make more informed decisions, aiming to improve patient outcomes and quality of life through more precise, individualized care.